Skip to content

Median effective dose of oliceridine combined with propofol for analgesia in elderly patients undergoing prostate biopsy

Median effective dose of oliceridine combined with propofol for analgesia in elderly patients undergoing prostate biopsy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117341
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated PSA

Interventions

Group E:The dose of oliceridine for each patient was determined using a modified Dixon sequential method
Group M:The dose of oliceridine for each patient was determined using a modified Dixon sequential method

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1: Older men planned for transperineal prostate biopsy under ultrasound guide; 2: Age >= 65 years; 3: BMI 18. 5~20. 0 kg/m^2; 4: ASA ?~?.

Exclusion criteria

Exclusion criteria: 1: use of sedatives or analgesics within 24 h before surgery; 2: difficult airway (modified Mallampati grade IV); 3: communication or cognitive impairment; 4: allergy to study drugs; 5: severe cardiovascular, pulmonary, hepatic, or renal dysfunction;

Design outcomes

Primary

MeasureTime frame
Oliceridine dose;

Secondary

MeasureTime frame
Intraoperative adverse reactions such as respiratory depression,hypotension and bradycardia;Satisfaction score of patients, anesthesiologists and surgeons;Occurrence of postoperative adverse reactions, such as dizziness and nausea/vomiting;

Countries

China

Contacts

Public ContactZhu Yunxia

Affiliated Hospital of Jiangnan University

zyx064221091011@126.com+86 138 1252 2816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026